CCL5 and neurodegenerative disease: Evidences have shown that RANTES and its receptor CCR5 play a role in a wide array of pathological conditions with neurodegenerative diseases such as PD, Alzheimer's disease (AD), multiple sclerosis, stroke, and HIV-associated dementia [7–9].